(Q42997555)

12 November 2017

title

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants (English)

1 reference

12 November 2017

1 reference

1 reference

5

1 reference

12 November 2017

4

Niall P Quinn

1 reference

12 November 2017

7

Anders Bjorklund

1 reference

12 November 2017

1

Marios Politis

1 reference

12 November 2017

9

Paola Piccini

1 reference

12 November 2017

3

Clare Loane

1 reference

12 November 2017

Kit Wu

2

1 reference

12 November 2017

Stig Rehncrona

series ordinal

6

1 reference

12 November 2017

Olle Lindvall

series ordinal

8

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Science Translational Medicine

12 November 2017

published in

1 reference

12 November 2017

volume

2

1 reference

12 November 2017

issue

38

1 reference

12 November 2017

page(s)

38ra46

1 reference

Cell therapy in Parkinson's disease

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Sequential bilateral transplantation in Parkinson's disease: effects of the second graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Transplanted dopaminergic neurons develop PD pathologic changes: a second case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Serotonergic stimulation of the ventrolateral striatum induces orofacial stereotypy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Assessing fetal nerve cell grafts in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000976

10.1126/SCITRANSLMED.3000976

21 January 2018

Identifiers

DOI

1 reference

release_zazrxnptrjeilgoe56junqm6du

12 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zazrxnptrjeilgoe56junqm6du

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference